In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes.
Where this comes from
- Record sourced from PubMed, PMID 35500259.
- Also identified by DOI 10.7326/J22-0029.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Agarwal R, Filippatos G, Pitt B, et al. <b>Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis.</b> Eur Heart J. 2022;43:474-84. 35023547.
Medical subject headings
- Diabetes Mellitus, Type 2
- Renal Insufficiency, Chronic